Progress and challenges in the development of COVID-19 vaccines and current understanding of SARS-CoV-2-specific immune responses

12Citations
Citations of this article
160Readers
Mendeley users who have this article in their library.

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is spreading globally, and the WHO has declared this outbreak a pandemic. Vaccines are an effective way to prevent the rapid spread of COVID-19. Furthermore, the immune response against SARS-CoV-2 infection needs to be understood for the development of an efficient and safe vaccine. Here, we review the current understanding of vaccine targets and the status of vaccine development for COVID-19. We also describe host immune responses to highly pathogenic human coronaviruses in terms of innate and adaptive immunities.

Cite

CITATION STYLE

APA

Kim, K. D., Hwang, I., Ku, K. B., Lee, S., Kim, S. J., & Kim, C. (2020). Progress and challenges in the development of COVID-19 vaccines and current understanding of SARS-CoV-2-specific immune responses. Journal of Microbiology and Biotechnology, 30(8), 1009–1015. https://doi.org/10.4014/jmb.2006.06006

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free